FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmacy and represents a hepatoprotective and antihepatotoxic pharmaceutical composition containing 200-400 mg of ademetionine and 100-200 mg of ursodeoxycholic acid and a pharmaceutically acceptable carrier, differing that it additionally contains 250-500 mg of taurine, 300-600 mg of thioctic acid, 140-300 mg of silimarin, 180-500 mg of L-arginine, 250-500 mg of L- carnitine, 250-2000 mg of L-tryptophane, 250-500 mg of L-glutathione or eltacine and 100-200 mg of artichoke extract.
EFFECT: invention provides extended range of products with high hepatoprotective and antihepatotoxic activity.
7 cl, 5 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED AGENT CONTAINING UDCA, HYMECROMONE AND SILYMARIN (VERSIONS) | 2017 |
|
RU2738444C2 |
| PHARMACEUTICAL HEPATOPROTECTIVE COMPOSITION AND TREATMENT METHOD | 2008 |
|
RU2391989C2 |
| PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
| SOLID MEDICINAL FORMULATION OF HEPATOPROTECTIVE EFFECT | 2006 |
|
RU2314797C2 |
| PHARMACEUTICAL COMPOSITION BASED ON HERBAL EXTRACTS FOR TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND SYPHILIS AND METHOD OF TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND SYPHILIS | 2009 |
|
RU2401121C1 |
| PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
| MEDICATION, POSSESSING HEPATOPROTECTIVE, DETOXICATING AND REGENERATING ACTION | 2007 |
|
RU2418601C2 |
| PHARMACEUTICAL COMPOSITION FOR PARENTERAL DRIP INTRODUCTION | 2019 |
|
RU2709502C1 |
| PHARMACEUTICAL COMPOSITION FOR PARENTERAL DRIP INTRODUCTION | 2019 |
|
RU2709501C1 |
| HERBAL AGENT POSSESSING HEPATOPROTECTIVE ACTION | 2014 |
|
RU2554493C1 |
